Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail

Eur Heart J. 2020 Nov 1;41(41):4008-4010. doi: 10.1093/eurheartj/ehaa661.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Heart Disease Risk Factors
  • Humans
  • Plasma
  • Primary Prevention
  • Proteomics*
  • Risk Factors